Professor Jiang Jianli's team from the Fourth Military Medical University came to Shenzhen Cell Valley Co-explore the new direction of cell therapy cooperation
Professor Jiang Jianli served as the deputy director of the Cell Engineering Research Center of the Fourth Military Medical University. He has been devoted to the basic and applied research of tumor cell biology for a long time, especially in the field of exploring the molecular regulation mechanism of the occurrence and development of liver cancer, and has made a number of important scientific research achievements with forward-looking and innovative significance. Professor Jiang has been in charge of a number of scientific research projects, such as the National "863" Program, the National Natural Science Foundation of China and the National Science and Technology Major Projects, and has won three national invention patents. He has published several high-influence academic papers, 32 of which were included in the SCI. In addition, Professor Jiang also served as the deputy editor of the book Engineering Cell Biology, and participated in the compilation of many academic works such as Cell Engineering, Basic and Clinical Studies of Cancer Markers and The Frontier of Cancer Research.
At the symposium, Professor Wang Jianxun said that our company has successfully prepared CAR-T cell products for multiple targets by using the self-produced industrial-grade retroviral vector, and has carried out clinical application in many public medical institutions in China. In terms of strategic deployment, Shenzhen Cell Valley has set up cell preparation centers in Yunnan and Henan provinces, and will continue to expand. The visit aims to strengthen the cooperation between the two sides in the field of cell therapy, and hopes to build a cell therapy center platform.
Professor Jiang Jianli pointed out that the on-site visit is a good opportunity for the two sides to deepen exchanges and jointly promote scientific research cooperation. He stressed that the development of cell therapy, as a frontier of medicine, must rely on close cooperation across disciplines and institutions. He looks forward to working with the Cell Valley team to use cell therapy technology to deeply study liver cancer and jointly promote the innovation and application of cell therapy technology.
This exchange marks the further deepening of the cooperation between Shenzhen Cell Valley and the Cell Engineering Research Center of the Fourth Military Medical University. Both sides expect to promote the clinical transformation process of cell therapy technology and bring hope and good news to many cancer patients.
